Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BMI and Cause-Specific Hospital Admissions and Costs: The UK Biobank Cohort Study.

O'Halloran R. et al, (2020), Obesity (Silver Spring)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

HALLIDAY A. et al, (2019), For Presentation at the European Society of Cardiology on 2nd September 2019

Impact of ADCY9 Genotype on Response to Anacetrapib.

HOPEWELL JC. et al, (2019), Circulation, 140, 891 - 898

Impact of variation in Type 2 diabetes care on health outcomes and healthcare costs

Keng MJ. et al, (2019), DIABETIC MEDICINE, 36, 161 - 161

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Mihaylova B. and Collaborative HT-R., (2018), EUROPEAN HEART JOURNAL, 39, 1054 - 1054

Fibroblast Growth Factor-23 and Risks of Cardiovascular and Non-cardiovascular Diseases: a Meta-analysis

Herrington W. et al, (2018), Journal of the American Society of Nephrology

Load More

Handbooks in Health Economic Evaluation

A series published by Oxford University Press.

Find out more